Full-Time

Senior Counsel

Corporate and Business Development

Posted on 4/16/2025

Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$225k - $260k/yr

+ Incentive Cash + Stock Opportunities

Senior, Expert

Company Historically Provides H1B Sponsorship

Cambridge, MA, USA + 5 more

More locations: Seattle, WA, USA | Summit, NJ, USA | Daly City, CA, USA | Princeton, NJ, USA | San Diego, CA, USA

Category
Business Development
Legal & Compliance
Business & Strategy
Requirements
  • Law degree. Qualification to practice law in New Jersey or ability to obtain a NJ in-house counsel limited license.
  • Minimum of 10 years of legal experience.
  • Experience drafting and negotiating complex transaction agreements related to the bio/pharmaceutical or life-sciences industry, including license agreements, collaboration agreements, acquisitions and divestitures.
  • Understanding of bio-pharmaceutical/life-sciences industry.
  • Has excellent interpersonal skills and can successfully manage internal client expectations and can work/operate well with a variety of personalities/capabilities in cross-functional teams, matrix environment.
  • Creative, thoughtful and practical problem-solving skills.
  • Must have high integrity, ability to assess risk, ability to make decisions and think strategically while applying knowledge of applicable legal issues.
  • Listens to internal client needs and communicates with clients with confidence and diplomacy.
  • Excellent verbal and writing skills and business judgment are required.
  • Ability to communicate effectively with management and senior management personnel.
  • Ability to train and develop the other members of the team.
  • Ability to work independently, effectively and efficiently and perform against broad objectives.
  • Possess strong work ethic.
Responsibilities
  • Lead drafting and negotiations, structuring and counseling on transactions (including mergers and acquisitions, strategic equity investments, strategic divestitures, global licenses, collaborations and partnerships and other transactions).
  • Identify and resolve critical legal issues and identify and help resolve critical business issues arising from transactions.
  • Oversee and manage the legal due diligence process.
  • Partner with Corporate Development and Business Development clients to ensure strategic alignment in all transactions, escalating matters as appropriate with the judgment to understand when escalation is necessary.
  • Manage business relationships and counsel business clients across a broad sphere of influence, internally and externally, on transaction and strategic issues pertaining to strategic alliance partnerships and collaborations.
  • Contribute to the on-going development of a high-performance transactions legal team and cultivate a highly collaborative culture with effective relationships with peers in the legal department as well as other key functions.
  • As appropriate, manage and organize antitrust approvals and negotiations with antitrust authorities and regulators.
  • Demonstrate a service-oriented approach to advising internal client groups.
  • Demonstrate full commitment to Bristol Myers Squibb’s mission and values.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high safety and quality standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medications, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery accelerates BMS's R&D, improving drug development efficiency.
  • BMS's acquisition of 2seventy bio enhances its cancer cell therapy capabilities.
  • Positive Phase 3 trial results for Sotyktu boost BMS's psoriatic arthritis treatment portfolio.

What critics are saying

  • Increased competition in oncology may impact BMS's market share.
  • Layoffs could decrease employee morale, affecting operational efficiency.
  • Integration challenges from acquiring 2seventy bio may pose financial risks.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company integrates AI in early lung cancer diagnosis, enhancing precision care.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

European HHHM
Apr 16th, 2025
Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis

Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has entered an agreement with Bristol Myers Squibb (NYSE: BMY), to leverage AI in early diagnosis and precision lung cancer care.

CMMB
Mar 24th, 2025
Our Values, Your Impact

In partnership with Bristol Myers Squibb, Catholic Medical Mission Board Inc. is playing a role in building the infrastructure and workforce to bring quality cancer care to rural Kenya.

PR Newswire
Mar 20th, 2025
Bristol Myers Squibb Appoints Osama Braiwish As General Manager For Saudi Arabia Gulf Countries

RIYADH, Saudi Arabia, March 20, 2025 /PRNewswire/ -- Bristol Myers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General Manager for Saudi Arabia and Gulf Countries, an affiliate covering Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan

Investors Hangout
Mar 20th, 2025
Bristol Myers Squibb Welcomes New Leadership in Gulf Region

Bristol Myers Squibb, a leader in the global biopharmaceutical sector, has appointed Osama Braiwish as its General Manager for the Gulf region, thereby enhancing its capacity to serve medical needs across various specialties.

Business Wire
Mar 12th, 2025
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all